ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Susan Hubbard Names Director Of International Cancer information Center; Includeds ICRDB, PDQ

September 14, 1984

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002

NIH Offers Curriculum Supplements For K-12

November 5, 1999

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

In Brief: Cancer Act Extension, Training Bill Breezing Through Congress; Army Causes Ft. Detrick Flap

July 5, 1974